Literature DB >> 9227487

Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line.

S C Linn1, P J Morelli, I Edry, S E Cottongim, C Szabó, A L Salzman.   

Abstract

The inducible form of nitric oxide synthase (iNOS) is expressed during inflammation of the intestine and may contribute to tissue injury. We have examined iNOS transcriptional regulation in DLD-1 cells, a human intestinal epithelial line that produces large amounts of nitric oxide and iNOS mRNA in response to a combination of the proinflammatory cytokines interleukin-1 beta (IL-1 beta) and interferon-gamma (IFN-gamma). Levels of iNOS mRNA are extremely low in unstimulated DLD-1 cells but increase dramatically after cytokine treatment. Nuclear run-on analyses demonstrated that transcriptional activation, which accounts for a portion of this increase, is dependent on both IL-1 beta and IFN-gamma and requires de novo protein synthesis. Transfection of DLD-1 cells with reporter constructs containing deletions of the iNOS promoter showed that sequences located between 8.7 and 10.7 kb upstream of the transcription initiation site are necessary for cytokine responsiveness. This region contains potential binding sites for several cytokine-induced transcription factors and was shown to function in either orientation when placed upstream of a basal iNOS promoter segment terminating at-1.1 kb. The extremely distal location of the cytokine-responsive region contrasts with the reported positions of elements involved in the regulation of iNOS transcription in other cell types. Our data also suggest that posttranscriptional events could play a significant role in regulating iNOS gene expression in human intestinal epithelia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227487     DOI: 10.1152/ajpgi.1997.272.6.G1499

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.

Authors:  M Cavicchi; B J Whittle
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria.

Authors:  David Burgner; Stanley Usen; Kirk Rockett; Muminatou Jallow; Hans Ackerman; Alessandra Cervino; Margaret Pinder; Dominic P Kwiatkowski
Journal:  Hum Genet       Date:  2003-01-28       Impact factor: 4.132

Review 3.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

4.  Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.

Authors:  M Hausding; A Witteck; F Rodriguez-Pascual; C von Eichel-Streiber; U Förstermann; H Kleinert
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.

Authors:  Sergio Di Marco; Rachid Mazroui; Patrice Dallaire; Sridar Chittur; Scott A Tenenbaum; Danuta Radzioch; Andre Marette; Imed-Eddine Gallouzi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.

Authors:  Kalipada Pahan; Malabendu Jana; Xiaojuan Liu; Bradley S Taylor; Charles Wood; Susan M Fischer
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

7.  Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinase.

Authors:  Tuija Turpeinen; Riina Nieminen; Ville Taimi; Taina Heittola; Outi Sareila; Andrew R Clark; Eeva Moilanen; Riku Korhonen
Journal:  Mediators Inflamm       Date:  2011-04-19       Impact factor: 4.711

Review 8.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

9.  NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans.

Authors:  Digna Rosa Velez; William F Hulme; Jamie L Myers; J Brice Weinberg; Marc C Levesque; Martin E Stryjewski; Eduardo Abbate; Rosa Estevan; Sara G Patillo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-07-03       Impact factor: 4.132

10.  Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Authors:  Marc C Levesque; Maurine R Hobbs; Charles W O'Loughlin; Jennifer A Chancellor; Youwei Chen; Ariana N Tkachuk; Jennifer Booth; Kistie B Patch; Sallie Allgood; Ann R Pole; Carolyn A Fernandez; Esther D Mwaikambo; Theonest K Mutabingwa; Michal Fried; Bess Sorensen; Patrick E Duffy; Donald L Granger; Nicholas M Anstey; J Brice Weinberg
Journal:  Hum Genet       Date:  2009-10-27       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.